Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

82.92 -0.66 (-0.79%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
35 36 Next >
Market Momentum: Your Weekly Financial Forecast
Originally published at VolumeLeaders What to expect for July 29- August 02, 2024 
Via Benzinga
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now. 
Via The Motley Fool
Demystifying DexCom: Insights From 15 Analyst Reviews
Via Benzinga
ON Semiconductor Posts Upbeat Earnings, Joins Oil States International, CommScope Holding And Other Big Stocks Moving Higher On Monday
Via Benzinga
Behind the Scenes of DexCom's Latest Options Trends
Via Benzinga
Despite its growth, NASDAQ:DXCM remains within the realm of affordability.
In the world of growth stocks, NASDAQ:DXCM shines as a value proposition. 
Via Chartmill
Why DexCom Stock Is Crashing Today
Investors are worried about the diabetes care technology leader's slowing growth. 
Via The Motley Fool
Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
From Tandem Diabetes Care, Inc.
Via Business Wire
DXCM Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
DXCM Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox &amp; Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - July 29, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against DexCom, Inc. (DXCM) (“DexCom” or the “Company”) (NASDAQ: DXCM). 
Via TheNewswire.com
Is Beaten-Down Dexcom Stock a Buy on the Dip?
The market may have overreacted to a disappointing earnings report. 
Via The Motley Fool
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
These profitable businesses have a lot to offer the long-term investor. 
Via The Motley Fool
Kaplan Fox & Kilsheimer LLP is Investigating Possible Securities Law Violations Against DexCom, Inc. (DXCM)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Kaplan Fox &amp; Kilsheimer LLP is Investigating Possible Securities Law Violations Against DexCom, Inc. (DXCM)
NEW YORK, NY - (NewMediaWire) - July 28, 2024 -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against DexCom, Inc. (DXCM) (“DexCom” or the “Company”) (NASDAQ: DXCM). 
Via TheNewswire.com
2 Magnificent Growth Stocks to Buy Right Now
These top stocks are looking increasingly attractive for a long-term investment. 
Via The Motley Fool
Kaplan Fox & Kilsheimer LLP is Investigating DexCom, Inc. (DXCM) for Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Kaplan Fox &amp; Kilsheimer LLP is Investigating DexCom, Inc. (DXCM) for Potential Securities Law Violations
NEW YORK, NY - (NewMediaWire) - July 26, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against DexCom, Inc. (DXCM) (“DexCom” or the “Company”) (NASDAQ: DXCM). 
Via TheNewswire.com
DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of DexCom Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DXCM INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into DexCom, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against DexCom, Inc. (DXCM)
From Kirby McInerney LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
Via Benzinga
Topics Stocks
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
After a turbulent week in the markets, the bulls reclaimed dominance on Wall Street during Friday’s session, with indices and sectors trading in positive territory as investors welcomed the latest... 
Via Benzinga
Topics Economy Stocks
Dow Recovers Weekly Losses With 600-Point Pop
The Dow Jones Industrial Average is soaring today, up 608 points at last look and breaking into positive territory for the week. 
Via Talk Markets
Topics Stocks
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
DXCM Investors Have Opportunity to Join DexCom, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Via Benzinga
DexCom Faces Short-Term Challenges, But Market Growth Prospects Remain Strong: Analyst
DexCom reports Q2 sales of $1.004B, up 15% YoY, with adjusted EPS of $0.43, beating the $0.39 consensus. Despite lowering 2024 sales guidance to $4.00-$4.05B, William Blair maintains an Outperform... 
Via Benzinga
Why DexCom Stock Is Trading Lower Friday
DexCom shares are trading lower Friday after the company reported worse-than-expected second quarter revenue and issued weak guidance. 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback